Mabwell Biotech
Is dedicated to providing better and more accessible treatments for patients through cutting-edge research.
Launch date
Employees
Market cap
-
Enterprise valuation
$1.1—1.7b (Dealroom.co estimates Apr 2020.)
Shanghai Shanghai (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $279m | Series A | |
* | N/A | $547m | IPO |
| Total Funding | $279m | ||
Related Content
Recent News about Mabwell Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.